These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911 [TBL] [Abstract][Full Text] [Related]
6. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events. Michelena HI; Osorio LA; Citkowitz E Int J Cardiol; 2005 May; 101(1):111-4. PubMed ID: 15860392 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes. Canas JA; Ross JL; Taboada MV; Sikes KM; Damaso LC; Hossain J; Caulfield MP; Gidding SS; Mauras N Pediatr Diabetes; 2015 Mar; 16(2):79-89. PubMed ID: 25418907 [TBL] [Abstract][Full Text] [Related]
9. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial. Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099 [TBL] [Abstract][Full Text] [Related]
10. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study. Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327 [TBL] [Abstract][Full Text] [Related]
11. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE Diabetologia; 1993 Oct; 36(10):1079-86. PubMed ID: 8243858 [TBL] [Abstract][Full Text] [Related]
12. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study. Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin. Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533 [TBL] [Abstract][Full Text] [Related]
14. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW; Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus. Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988 [TBL] [Abstract][Full Text] [Related]
16. Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes. Guyton JR; Betteridge DJ; Farnier M; Leiter LA; Lin J; Shah A; Johnson-Levonas AO; Brudi P Diab Vasc Dis Res; 2011 Apr; 8(2):160-72. PubMed ID: 21562068 [TBL] [Abstract][Full Text] [Related]
17. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Szendroedi J; Anderwald C; Krssak M; Bayerle-Eder M; Esterbauer H; Pfeiler G; Brehm A; Nowotny P; Hofer A; Waldhäusl W; Roden M Diabetes Care; 2009 Feb; 32(2):209-14. PubMed ID: 18957532 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial. Goldberg AC; Sapre A; Liu J; Capece R; Mitchel YB; Mayo Clin Proc; 2004 May; 79(5):620-9. PubMed ID: 15132403 [TBL] [Abstract][Full Text] [Related]
19. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698 [TBL] [Abstract][Full Text] [Related]
20. Effects of medical therapies on retinopathy progression in type 2 diabetes. ; ; Chew EY; Ambrosius WT; Davis MD; Danis RP; Gangaputra S; Greven CM; Hubbard L; Esser BA; Lovato JF; Perdue LH; Goff DC; Cushman WC; Ginsberg HN; Elam MB; Genuth S; Gerstein HC; Schubart U; Fine LJ N Engl J Med; 2010 Jul; 363(3):233-44. PubMed ID: 20587587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]